May Budget lead to ‘Make in India’ Ecosystem for Medical Devices

Budget Reaction by Medical Device Industry
Mr Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
“It is heartening to note the commitment from the Finance Minister Arun Jaitley in this budget regarding ‘regulations for medical devices in the country.’ However, the statement is too open-ended and the fine print is yet to be spelled out. We do hope the coming road map will be in sync with the Government’s larger commitment of ‘Make in India’ i.e to develop manufacturing eco-system for the medical devices in the country, boosting domestic industry while ensuring the healthcare security of the nation which implies that cost of medical devices need to be lowered.”

Related Posts

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug